Genetic Markers in Prostate Cancer Management

When a prostate biopsy is performed, tiny thread-like “cores” are obtained through the tip of a needle attached to a biopsy gun. These tiny specimens are sent to a highly trained pathologist to examine the tissue under a high-powered microscope. The appearance of prostate cells and their architecture help determine the presence or absence of… Read more »

Clinical Trial Subject Perspective

We previously published Understanding Clinical Trials (July/Aug 2014) featuring an interview with Don Anderson, MD, principal investigator at Desert Valley Research. As a follow-up to that story, Desert Medical Imaging presented a client, Ed Dykstra, who wanted to share his story from the perspective of a clinical trial subject. Following is our interview with Ed:… Read more »

To Screen or Not to Screen? That is the Question

Making a decision to be screened for certain medical conditions can be difficult, especially when the recommendations and guidelines are constantly changing. September is Prostate Cancer Awareness Month and October is Breast Cancer Awareness Month, so it is timely to review the recommendations of various organizations for both of these conditions. What is a screening… Read more »

The Importance of an Accurate Gleason Score for the Treatment of Prostate Cancer

Prostate cancer is the most common non-skin cancer in men. About 240,000 American men are diagnosed with prostate cancer each year, and in 130,000, the cancer is localized and low-risk. Although most prostate cancers are slow growing and unlikely to spread, most men receive immediate treatment with surgery or radiation. These therapeutic strategies are associated… Read more »